RxDoctor Payments Data

Wasik Ashraf, DO

Orthopaedic Surgery · New Windsor, NYNPI 1114158250

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $419,335 of the $656,587 with a category attached, or 63.9%. 26 manufacturers reported payments, led by Zimmer Biomet at 36.5% of the total. Reporting peaked in 2023 at $326,956 and has fallen 93.3% since, to $21,797 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$656,587in general payments, 2019–2025

Across 568 payments — averaging $1155.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$240K
  • Anika Therapeutics, Inc.$181K
  • Medical Device Business Services, Inc.$117K
  • Geistlich Pharma, North America, Inc.$39K
  • Embody, Inc.$27K
  • Linvatec Corporation$22K
  • plus $31K from 20 others
$490,212in research payments, 2019–2025

Across 32 payments — averaging $15,319 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$438K
  • Biorez, Inc.$52K

What the payments were for

  • Consulting fees$419,33564%
  • Speaking & faculty fees$23,1734%
  • Travel & lodging$55,9369%
  • Food & beverage$21,9013%
  • Education$6250%
  • Other$135,61721%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$656,587 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$64,867
Medicare patients
87
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$98
Meloxicam16$81

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New Windsor

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →